AUDIO from Medialink and AARP: Helping Older Americans Buy Groceries i...( NEW YORK June 29 /- An estimated 3.6 ...),Health
Navigation Links
AUDIO from Medialink and AARP: Helping Older Americans Buy Groceries in a 'Snap'
Date:6/29/2009
NEW YORK, June 29 /PRNewswire/ -- An estimated 3.6 million Americans over age sixty-five are living in poverty. Many must choose between going to the grocery store and paying their bills. Here's more from one advocacy group who wants to make sure no one, especially the elderly poor, has to make this choice.
Listen to this report from AARP at: http://inr.mediaseed.tv/oneClip_C/?feed=WsZJ1t1vnHTxUfGPymBDxUQo0PBhdDQB
Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.
06DC09-0105
'/>"/>
| SOURCE Medialink; AARP Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Lumension Audiocast With Aberdeen Group Highlights How to Reduce IT Costs By Effectively Managing and Securing Endpoints
2. AUDIO from Medialink and Siemens: New Tool in the Battle Against Breast Cancer
3. OB10 and Memorial Hermann to Co-host June 17 Audio Conference on e-Invoicing and PCard Spend
4. AUDIO from Medialink and Amgen: Experts Agree Infection in Cancer Patients Impacts Treatment Success
5. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
6. AUDIO from Medialink and Procter & Gamble: Feel Better on the Beach - Inside and Out
7. AUDIO from Medialink and the Alzheimers Foundation of America: Strategies for Healthy Aging
8. AUDIO from Medialink and UnitedHealthcare Group: Its National Nurses Week
9. AUDIO from Medialink and Ovations: Living Long and Living Well
10. AUDIO from Medialink and the McKesson Settlement Administrator: McKesson Settlement
11. AUDIO from Medialink and Prescription Solutions: Prescription Solutions - A Drug Interaction Alert
Post Your Comments:
(Date:11/23/2009)...emo deal with insomnia, study shows , , ...leep disorders affect more than three-quarters of ...arly three times higher than that of the general p...more common in younger patients and in those with ...ter Medical Center researchers, who assessed sleep...
(Date:11/23/2009)...ewswire/--Hazelden,theinternationallyrenownednonpr...ershipteamforitsnewrecoverycenterinNaples,Florida....nlateMarch2010,andwillinitiallyprovideaddictiontre...yandoutpatientservices. ,, MichaelDemask,Ph.D.,...Naples,withBrendaIliff,M.A.,L.A.D.C.,asclinicaldir...
(Date:11/23/2009)...e-USNewswire/-- The AmericanLegislativeExchangeCo...passociationofstatelegislators,congratulatesSouthC... constitutionalamendment toprotecttherightofindivi...nowbecomesthe24thstatewherelegislatorshaveintroduc...reedomofChoiceinHealthCareAct . ,, (Logo: http:...
(Date:11/23/2009)...ence Writings at Stevens Institute of Technology w...rt Wright, journalist and founder, Bloggingheads.t...the Babbio Center for Technology Management, Room ...the media., In his new book "The Evolution of Go...wned for his popular works on evolutionary psychol...
(Date:11/23/2009)...udent Jennifer Heys wants to make her message clea...munities about contraception. , Heys, research,...ear more children, was read by experts from all ov...tional Conference on Family Planning in Kampala, U...ic Health, spent six months interviewing 421 peopl...
Breaking Medicine News(10 mins):Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2[0] Sleep Disorders Plague Cancer Patients [1] Hazelden Names Leadership Team for New Recovery Center in Naples, Florida[1] South Carolina Now 24th State to Defend Health Care Choice[0] The Center for Science Writings presents 'The Evolution of God,' Dec. 2[0] AIDS research reveals a lack of family-planning programs in Uganda
...20 /PRNewswire-FirstCall/ - Hard to Treat Diseases...ce that the first batch of Influenca Vaccine (MEVA...so attend the tender of 2.5 million doses of influ...ne in Chile. The ISP (Instituto De Salud Publica d...
...0 Matrex Exhibits announces Bruce Bennett has rec... as Senior Account Executive. Bennett comes to Mat...focus on the medical, pharmaceutical, and healthca... offer," Bennett says. "Being able to guarantee ou...
...usive Relationships , , SEYMOUR, Tenn., March 20 ...ed by their significant others, many people wonder...ms to have it all. The situation becomes even more...n who will endure physical abuse of all kinds beca...
... rigorous environmental cleaning intervention can ...Staphylococcus aureus (MRSA) and other multidrug-...ts (ICUs), according to a new study presented toda...reduced the spread of MRSA to patients exposed to ...
... In 2005, the Scandinavian Prostate Cancer Group S...y improved prostate cancer survival compared with ...llow-up. At the 24th Annual EAU Congress in Stockh...dominantly included men whose prostate cancer was ...
... James S. Gordon, M.D., the distinguished psychi...for Mind-Body Medicine (CMBM), has just returned f...timony from people and institutions who were targe...ed, and their difficulty accepting Israel,s role i...
Other Medicine News:Health News:HARD TO TREAT DISEASES (HTDS) Influenca Vaccine (MEVAC-FLU) Enters Chilean Market 2Health News:What's Love Got to Do With It? 2Health News:What's Love Got to Do With It? 3Health News:Environmental Cleaning Intervention Reduces Transmission of Multidrug-Resistant Organisms in ICUs 2Health News:SPCG-4 trial: Update on watchful waiting versus radical prostatectomy 2Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 2Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 3Health News:New Hope & Resilience After Destruction and Killings in Gaza, Israel 4HARD TO TREAT DISEASES (HTDS) Influenca Vaccine (MEVAC-FLU) Enters Chilean MarketMATREX EXHIBITS Welcomes Industry VeteranWhat's Love Got to Do With It?Environmental Cleaning Intervention Reduces Transmission of Multidrug-Resistant Organisms in ICUsSPCG-4 trial: Update on watchful waiting versus radical prostatectomyNew Hope & Resilience After Destruction and Killings in Gaza, Israel
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- CumberlandPharmaceutical...esultsfromastudyevaluatingthesafetyandefficacyofCa...talizedburnpatients. ,, Statisticalsignificance...urnpatientsoverthefirst24hoursoftreatment.Thestudy...eburnscoveringmorethan10percenttotalbodysurfaceare...
(Date:11/23/2009)...3/PRNewswire-FirstCall/--WoundManagementTechnologi...iderofspecialtymedicalproducts,announcedthatithasf...ensivemanagementbusinessupdatetoillustratethedevel...esincreased33.5%to$102,926vs.Q32008salesof$77,084....3,327,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...swire-FirstCall/--CordBloodAmerica,Inc.(OTCBulleti...tioncompany( http://www.cordblood-america.com )foc...iologicalinsurancepolicy,tofamiliesnationwideandin...nterviewwithCEOandco-founderMatthewSchisslerisnowa...p.tv/file/2875811 . ,, Intheinterview,Mr.Schiss...
Breaking Medicine Technology:Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India 14487 1SIRO Clinpharm Strengthens its Clinical Trials Supplies Service Offering in India 14487 2Verathon Introduces the GlideScope 28R 29 Cobalt Advanced Video Laryngoscope 28AVL 29 3B New Digital Technology Facilitates Quick Intubations 5517 1Verathon Introduces the GlideScope 28R 29 Cobalt Advanced Video Laryngoscope 28AVL 29 3B New Digital Technology Facilitates Quick Intubations 5517 2American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 1American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 2American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 3American Lung Association in Colorados Faces of Influenza Initiative Rolls Up its Sleeves to Kick Off Flu Season in Denver 5514 4[0] Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients[0] Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update[0] Cord Blood America CEO Matthew Schissler Interviewed on Company's Progress
...bitor being developed for the ...ed a compelling 2.5% reduction in HbA1c in refract... -- ARI-2243 is a first-in-class "soft drug" conf...ectivity, -- Nonclinical toxicology evaluation sh... index, BOSTON, March 11 Arisaph ...
...vately held,biopharmaceutical company focused on t...oxygen transport agents, today announced that an,i... recommended the,continuation of both Phase III cl...roduct, Hemospan(R), under current protocols., Th... the blinded data,from the first two-thirds of the...
Other Medicine Technology:FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 2FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 3FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 4FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008 5Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |